https://idataresearch.com/wp-content/uploads/2016/04/ReportIcon-Video-MC.jpg

Surgical Robotics Systems Market Analysis | Australia | 2017-2023 | MedCore

  • Year: 2017
  • Scope: 2013-2023
  • Region: Australia
  • Pages: 589
  • Published Date: 2/1/2017
  • Type: MedCore

The ASP of the system has been reasonably stable since the release of the product, although there several discounts that are given which changes the ASP year after year, depending on whether the system is an upgrade, a new sale or part of a bundled package. The company has a 3-tiered business model in which revenues come from new sales, a percent fee of the purchase price of the system per year and the sales of three kinds of disposable kits which can be purchased, depending on the procedure.

Surgical robotics has tremendous potential to increase the effectiveness of existing procedures and to facilitate novel procedure types. The surgical robotics industry is, in many ways, still in its infancy, with more products in development than currently commercially available on the market. Early surgical robotics systems were based on industrial robots; however, most new surgical robotic systems are designed for highly specialized medical applications, which is a major drawback for most facilities.

Segments Covered in This Market

  • Robotics System Market
  • Robotics Fees, Services and Maitenance Revenue

Report Data Types Included

  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • 10 Year Scope (3 Year Historical + 7 Year Forecast Period)
  • Market Drivers & Limiters for Each Segment
  • Competitive Analysis with Market Shares
  • Product Portfolios
  • Related Press Releases from Top Competitors

Companies Analyzed

Mazor Robotics signed a commercial co-promotion and co-development agreement with Medtronic in 2016. Shortly afterward, the company unveiled its Mazor X™ system. The Mazor X™ is intended to enhance predictability and increase patient benefits by using precision tracking and optical guidance.

About Our In-Depth MedCore Research

Our analysts meticulously research for up to 3 to 4 months to put together one suite of reports (MedSuite), which is a comprehensive analysis on a group of healthcare markets. A MedCore is one portion of that analysis that focuses on one market segment, and provides further detailed segmentation to get a much more granular set of market data.

This MedCore is also found in the full report suite titled Australia Market Report Suite for Surgical Navigation and Robotics Systems – MedSuite

Learn More about these product types

TABLE OF CONTENTS I
LIST OF FIGURES XXI
LIST OF CHARTS XXVI
EXECUTIVE SUMMARY 1
AUSTRALIA ROBOTICS AND SURGICAL NAVIGATION MARKET OVERVIEW 1
COMPETITIVE ANALYSIS 5
MARKET TRENDS 7
MARKET DEVELOPMENTS 8
MARKETS INCLUDED 8
KEY REPORT UPDATES 9
VERSION HISTORY 9
RESEARCH METHODOLOGY 10
1.1 RESEARCH SCOPE 10
1.2 IDATA’S 9-STEP METHODOLOGY 10
Step 1: Project Initiation & Team Selection 10
Step 2: Prepare Data Systems and Perform Secondary Research 12
Step 3: Preparation for Interviews & Questionnaire Design 13
Step 4: Performing Primary Research 14
Step 5: Research Analysis: Establishing Baseline Estimates 16
Step 6: Market Forecast and Analysis 17
Step 7: Identify Strategic Opportunities 19
Step 8: Final Review and Market Release 20
Step 9: Customer Feedback and Market Monitoring 21
DISEASE OVERVIEW 22
2.1 MEDICAL CONDITIONS 22
2.1.1 Neurosurgery Conditions 22
2.1.1.1 Hydrocephalus 22
2.1.1.2 Communicating Hydrocephalus 22
2.1.1.3 Normal Pressure Hydrocephalus 23
2.1.1.4 Non-Communicating Hydrocephalus 23
2.1.1.5 Brain Tumor 23
2.1.1.6 Intracranial Pressure 23
2.1.1.7 Intracranial Aneurysm 23
2.1.1.8 Intracranial Atherosclerosis Disease 23
2.1.2 Spinal Conditions 25
2.1.2.1 Herniated Disc 25
2.1.2.2 Spinal Stenosis 25
2.1.2.3 Spondylosis 25
2.1.2.4 Scoliosis 25
2.1.2.5 Lordosis 25
2.1.2.6 Kyphosis 26
2.1.3 ENT Conditions 27
2.1.3.1 Otitis Media 27
2.1.3.2 Cholesteatomas 27
2.1.3.3 Otosclerosis 27
2.1.3.4 Chronic Sinusitis 27
2.1.3.5 Tonsillitis 27
2.1.4 Orthopedic Conditions 28
2.1.4.1 Fractures 28
2.1.4.2 Osteoporosis 28
2.1.4.3 Arthritis 28
2.1.5 Gynecological Conditions 28
2.1.5.1 Gynecological Cancers 28
2.1.5.2 Uterine Fibroids 29
2.1.5.3 Endometriosis 29
2.1.5.4 Menorrhagia 29
2.1.5.5 Pelvic Prolapse 29
2.1.6 Urological Conditions 31
2.1.6.1 Prostate Cancer 31
2.1.6.2 Bladder Cancer 31
2.1.6.3 Kidney Cancer 31
2.1.6.4 Benign Prostate Hyperplasia (BPH) 32
2.1.7 Digestive Tract Conditions 33
2.1.7.1 Achalasia 33
2.1.7.2 Stomach Cancer 33
2.1.7.3 Hernia 33
2.1.7.4 Gallbladder Attack 33
2.1.7.5 Gastroesophageal Reflex Disease 34
2.1.8 Colorectal Conditions 35
2.1.8.1 Colorectal Cancer 35
2.1.8.2 Inflammatory Bowel Disease 35
2.1.8.3 Diverticulitis 35
2.1.9 Cardiac Conditions 37
2.1.9.1 Mitral Valve Prolapse 37
2.1.9.2 Coronary Artery Disease 37
PRODUCT ASSESSMENT 38
3.1 ROBOTIC ASSISTED SURGERY PRODUCT PORTFOLIOS 38
3.1.1 Robotic-Assisted Surgery Overview 38
3.1.2 Neurosurgery 39
3.1.3 Spine Surgery 41
3.1.4 Orthopedic Surgery 43
3.1.5 Minimally Invasive Surgery 45
3.1.6 Radiosurgery 46
3.1.7 Catheter Placement 47
3.2 RAS REGULATORY ISSUES AND RECALLS 48
3.2.1 Accuray Inc. 48
3.2.2 Blue Belt Technologies 50
3.2.3 Hansen Medical Inc. 51
3.2.4 Intuitive Surgical 52
3.2.5 MAKO Surgical/Stryker 71
3.2.6 OMNIlife Science 73
3.3 CLINICAL TRIALS 75
3.4 RAS CLINICAL TRIALS 76
3.4.1 Accuray Inc. 76
3.4.2 Catheter Precision 82
3.4.3 Corindus Inc 84
3.4.4 Hansen Medical 86
3.4.5 Intuitive Surgical 87
3.4.6 MAKO Surgical/Stryker 90
3.4.7 Mazor 93
3.4.8 Medrobotics 96
3.4.9 Medtech 97
SURGICAL ROBOTICS MARKET 98
4.1 INTRODUCTION 98
4.2 SPINE ROBOTIC ASSISTED SURGERY SYSTEM MARKET 100
4.2.1 Introduction 100
4.2.2 Market Analysis and Forecast 100
4.2.3 Drivers and Limiters 105
4.2.3.1 Market Drivers 105
4.2.3.2 Market Limiters 105
4.2.4 Leading Competitors 108
4.2.5 Emerging Competitors 109
4.3 NEUROSURGERY ROBOTIC ASSISTED SURGERY SYSTEM MARKET 110
4.3.1 Introduction 110
4.3.2 Market Analysis and Forecast 110
4.3.3 Drivers and Limiters 115
4.3.3.1 Market Drivers 115
4.3.3.2 Market Limiters 115
4.3.4 Leading Competitors 117
4.3.5 Emerging Competitors 120
4.4 MINIMALLY INVASIVE SURGERY ROBOTIC DEVICE MARKET 121
4.4.1 Introduction 121
4.4.2 Market Analysis and Forecast 121
4.4.3 Drivers and Limiters 126
4.4.3.1 Market Drivers 126
4.4.3.2 Market Limiters 126
4.4.4 Leading Competitors 128
4.4.5 Emerging Competitors 129
4.5 ROBOTIC ASSISTED ORTHOPEDIC SURGERY MARKET 130
4.5.1 Introduction 130
4.5.2 Market Analysis and Forecast 130
4.5.3 Drivers and Limiters 135
4.5.3.1 Market Drivers 135
4.5.3.2 Market Limiters 135
4.5.4 Leading Competitors 138
ABBREVIATIONS 141
APPENDIX: COMPETITOR PRESS RELEASES 143
The "Australia Market Report Suite for Surgical Navigation and Robotics Systems 2017 - MedSuite" includes analysis on the following companies currently active in this market:
Brainlab
Medtronic
Stryker
Karl Storz
*Not all companies are currently active in every segment or sub-report from this suite. For more details contact an iData Research Product Advisor.
Chart 1 1: Surgical Navigation System Market by Segment, Australia, 2013 – 2023 3
Chart 1 2: Surgical Robotics System Market by Segment, Australia, 2013 – 2023 3
Chart 1 3: Robotics and Surgical Navigation Service and Maintenance Market Overview, Australia, 2016 & 2023 4
Chart 4 1: Spine Robotic Assisted Surgery System Market, Australia, 2013 – 2023 104
Chart 4 2: Neurosurgery Robotic Assisted Surgery System Market, Australia, 2013 – 2023 114
Chart 4 3: Leading Competitors, Neurosurgery Robotic Assisted Surgery System Market, Australia, 2016 119
Chart 4 4: Minimally Invasive Surgery Robotic Device Market, Australia, 2013 – 2023 125
Chart 4 5: Robotic Assisted Orthopedic Surgery Market, Australia, 2013 – 2023 134
Chart 4 6: Leading Competitors, Robotic Assisted Orthopedic Surgery Market, Australia, 2016 140

Figure 1 1: Robotics and Surgical Navigation Systems Competitor Market Share Ranking by Segment, Australia, 2016 (1 of 2) 5
Figure 1 2: Robotics and Surgical Navigation Systems Competitor Market Share Ranking by Segment, Australia, 2016 (2 of 2) 6
Figure 1 3: Companies Researched in this Report, Australia, 2016 6
Figure 1 4: Factors Impacting the Robotics and Surgical Navigation Systems Market by Segment, Australia, 2016 7
Figure 1 5: Recent Events in the Robotics and Surgical Navigation Market, Australia, 2013 – 2016 8
Figure 1 6: Robotics and Surgical Navigation Markets Covered, Australia, 2016 8
Figure 1 7: Key Report Updates 9
Figure 1 8: Version History 9
Figure 3 1: Robot-Assisted Neurosurgery Products by Company 40
Figure 3 2: Robot-Assisted Spine Surgery Products by Company 41
Figure 3 3: Robot-Assisted Orthopedic Surgery Products by Company 44
Figure 3 4: Robot-Assisted Radiosurgery Products by Company 46
Figure 3 5: Robot-Assisted Catheter Placement Products by Company 47
Figure 3 6: Class 2 Device Recall Accuray Inc 48
Figure 3 7: Class 2 Device Recall Accuray Inc 48
Figure 3 8: Class 2 Device Recall Accuray Inc 48
Figure 3 9: Class 2 Device Recall Accuray Inc 49
Figure 3 10: Class 2 Device Recall Accuray Inc 49
Figure 3 11: Class 2 Device Recall Accuray Inc 49
Figure 3 12: Class 2 Device Recall Blue Belt Technologies 50
Figure 3 13: Class 2 Device Recall Blue Belt Technologies 50
Figure 3 14: Class 2 Device Recall Blue Belt Technologies 50
Figure 3 15: Class 2 Device Recall Hansen Medical 51
Figure 3 16: Class 2 Device Recall Hansen Medical 51
Figure 3 17: Class 2 Device Recall Hansen Medical 51
Figure 3 18: Class 2 Device Recall Intuitive Surgical 52
Figure 3 19: Class 2 Device Recall Intuitive Surgical 52
Figure 3 20: Class 2 Device Recall Intuitive Surgical 52
Figure 3 21: Class 2 Device Recall Intuitive Surgical 53
Figure 3 22: Class 2 Device Recall Intuitive Surgical 53
Figure 3 23: Class 2 Device Recall Intuitive Surgical 53
Figure 3 24: Class 2 Device Recall Intuitive Surgical 54
Figure 3 25: Class 2 Device Recall Intuitive Surgical 54
Figure 3 26: Class 2 Device Recall Intuitive Surgical 55
Figure 3 27: Class 2 Device Recall Intuitive Surgical 55
Figure 3 28: Class 2 Device Recall Intuitive Surgical 56
Figure 3 29: Class 2 Device Recall Intuitive Surgical 57
Figure 3 30: Class 2 Device Recall Intuitive Surgical 57
Figure 3 31: Class 2 Device Recall Intuitive Surgical 57
Figure 3 32: Class 2 Device Recall Intuitive Surgical 58
Figure 3 33: Class 2 Device Recall Intuitive Surgical 58
Figure 3 34: Class 2 Device Recall Intuitive Surgical 59
Figure 3 35: Class 2 Device Recall Intuitive Surgical 59
Figure 3 36: Class 2 Device Recall Intuitive Surgical 59
Figure 3 37: Class 2 Device Recall Intuitive Surgical 60
Figure 3 38: Class 2 Device Recall Intuitive Surgical 60
Figure 3 39: Class 2 Device Recall Intuitive Surgical 60
Figure 3 40: Class 2 Device Recall Intuitive Surgical 61
Figure 3 41: Class 2 Device Recall Intuitive Surgical 61
Figure 3 42: Class 2 Device Recall Intuitive Surgical 62
Figure 3 43: Class 2 Device Recall Intuitive Surgical 63
Figure 3 44: Class 2 Device Recall Intuitive Surgical 63
Figure 3 45: Class 2 Device Recall Intuitive Surgical 64
Figure 3 46: Class 2 Device Recall Intuitive Surgical 64
Figure 3 47: Class 2 Device Recall Intuitive Surgical 65
Figure 3 48: Class 2 Device Recall Intuitive Surgical 65
Figure 3 49: Class 2 Device Recall Intuitive Surgical 65
Figure 3 50: Class 2 Device Recall Intuitive Surgical 66
Figure 3 51: Class 2 Device Recall Intuitive Surgical 66
Figure 3 52: Class 2 Device Recall Intuitive Surgical 66
Figure 3 53: Class 2 Device Recall Intuitive Surgical 67
Figure 3 54: Class 2 Device Recall Intuitive Surgical 67
Figure 3 55: Class 2 Device Recall Intuitive Surgical 67
Figure 3 56: Class 2 Device Recall Intuitive Surgical 68
Figure 3 57: Class 2 Device Recall Intuitive Surgical 68
Figure 3 58: Class 2 Device Recall Intuitive Surgical 68
Figure 3 59: Class 2 Device Recall Intuitive Surgical 68
Figure 3 60: Class 2 Device Recall Intuitive Surgical 69
Figure 3 61: Class 2 Device Recall Intuitive Surgical 69
Figure 3 62: Class 2 Device Recall Intuitive Surgical 69
Figure 3 63: Class 2 Device Recall MAKO Surgical/Stryker 71
Figure 3 64: Class 2 Device Recall MAKO Surgical/Stryker 71
Figure 3 65: Class 2 Device Recall MAKO Surgical/Stryker 71
Figure 3 66: Class 2 Device Recall MAKO Surgical/Stryker 72
Figure 3 67: Class 2 Device Recall MAKO Surgical/Stryker 72
Figure 3 68: Class 2 Device Recall MAKO Surgical/Stryker 72
Figure 3 69: Class 2 Device Recall OMNIlife Science, Inc 73
Figure 3 70: Class 2 Device Recall OMNIlife Science, Inc 73
Figure 3 71: Class 2 Device Recall OMNIlife Science, Inc 73
Figure 3 72: Class 2 Device Recall OMNIlife Science, Inc 74
Figure 3 73: Class 2 Device Recall OMNIlife Science, Inc 74
Figure 3 74: Endoscopic Evaluation of Late Rectal Injury Following CyberKnife Radiosurgery for Prostate Cancer 76
Figure 3 75: CyberKnife Stereotactic Radiosurgery for Low and Intermediate Risk Prostate Cancer 76
Figure 3 76: A Phase II Trial of CyberKnife Stereotactic Radiosurgery to Prostate Tumors 77
Figure 3 77: Study To Establish Maximum Tolerated Dose (MTD) of Cyberknife in Patients 77
Figure 3 78: A Phase II Trial of CyberKnife Radiosurgery to Perioptic Tumors 78
Figure 3 79: Evaluation of CyberKnife Stereotactic Radiotherapy in Prostate Cancer 78
Figure 3 80: An Effectiveness and Toxicity of CyberKnife Based Radiosurgery for Parkinson Disease 79
Figure 3 81: CyberKnife Stereotactic Accelerated Partial Breast Irradiation (SAPBI) (CK-SAPBI) 79
Figure 3 82: Safety and Efficacy Study of Five-fraction Stereotactic Body Radiation Therapy 80
Figure 3 83: A Study of Pre-Operative Cyberknife in Patients With Potentially Resectable Pancreas Cancer 80
Figure 3 84: Stereotactic Radiosurgery for Soft Tissue Sarcoma 81
Figure 3 85: A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma 81
Figure 3 86: Safety and Feasibility of Arrhythmia Ablation Using the Amigo Remote Robotic System 82
Figure 3 87: Evaluation of the Amigo Robotic System for Ablation of the Cavo-Tricuspid Isthmus 82
Figure 3 88: Manual vs Amigo SmartTouch Atrial Fibrillation Study (MAST-AF) 83
Figure 3 89: Robotic-Assisted Peripheral Intervention for Peripheral Arterial Disease (RAPID) 84
Figure 3 90: Robotic-Assisted Peripheral Intervention for Peripheral Arterial Disease II (RAPID II) 84
Figure 3 91: Post-Market CorPath Registry on the CorPath 200 System 85
Figure 3 92: Embolization Procedures in the Peripheral Vasculature Using the Magellan™ Robotic System 86
Figure 3 93: Registry of the Magellan Robotic System (ROVER) 86
Figure 3 94: Evaluation of Clinical Outcomes in Robotic-Assisted Inguinal Hernia Repair 87
Figure 3 95: A Retrospective Multicenter Investigation of the Use of the da Vinci® Surgical System 87
Figure 3 96: Cosmesis, Patient Satisfaction and Quality of Life After da Vinci 88
Figure 3 97: Robotic-assisted Versus Laparoscopic Sigmoid Resection 88
Figure 3 98: Prospective Investigation of Robotic Single-port System 89
Figure 3 99: Clinical Outcomes of Knee Replacement 90
Figure 3 100: A Trial Evaluating TKR Compared to BKR Performed Using Stryker's Mako Robot 90
Figure 3 101: Robotic Arm Assisted Total Knee Arthroplasty 91
Figure 3 102: Outcomes of Robotic Total Hip Arthroplasty 91
Figure 3 103: Clinical and Economic Comparison of Robot Assisted Versus Manual Knee Replacement 92
Figure 3 104: Prospective, Observational Registry of Renaissance-guided Spine Surgeries 93
Figure 3 105: Clinical Trial of Minimally Invasive Robotic Spine Surgery 93
Figure 3 106: Robotic vs. Freehand Corrective Surgery for Pediatric Scoliosis (PEDSCOLI) 94
Figure 3 107: ADDRESS - Adult Deformity Robotic vs. Freehand Surgery to Correct Spinal Deformity 94
Figure 3 108: MIS ReFRESH: Robotic vs. Freehand Minimally Invasive Spinal Surgeries 95
Figure 3 109: A Post-Market Clinical Trial for Access and Visualization 96
Figure 3 110: Robotic-assisted Pedicule Screw Placement (ARASS) 97
Figure 4 1: Total Spine Robotic Assisted Surgery System Market, Australia, 2013 – 2023 101
Figure 4 2: Spine Robotic Assisted Surgery System Market, Australia, 2013 – 2023 (US$) 102
Figure 4 3: Spine Robotic Assisted Surgery System Market, Australia, 2013 – 2023 (AU$) 103
Figure 4 4: Drivers and Limiters, Spine Robotic Assisted Surgery System Market, Australia, 2016 107
Figure 4 5: Leading Competitors, Spine Robotic Assisted Surgery System Market, Australia, 2016 108
Figure 4 6: Total Neurosurgery Robotic Assisted Surgery System Market, Australia, 2013 – 2023 111
Figure 4 7: Neurosurgery Robotic Assisted Surgery System Market, Australia, 2013 – 2023 (US$) 112
Figure 4 8: Neurosurgery Robotic Assisted Surgery System Market, Australia, 2013 – 2023 (AU$) 113
Figure 4 9: Drivers and Limiters, Neurosurgery Robotic Assisted Surgery System Market, Australia, 2016 116
Figure 4 10: Leading Competitors, Neurosurgery Robotic Assisted Surgery System Market, Australia, 2016 118
Figure 4 11: Total Minimally Invasive Robotic Assisted Surgery System Market, Australia, 2013 – 2023 122
Figure 4 12: Minimally Invasive Surgery Robotic Device Market, Australia, 2013 – 2023 (US$) 123
Figure 4 13: Minimally Invasive Surgery Robotic Device Market, Australia, 2013 – 2023 (AU$) 124
Figure 4 14: Drivers and Limiters, Minimally Invasive Surgery Robotic Device Market, Australia, 2016 127
Figure 4 15: Leading Competitors, Minimally Invasive Surgery Robotic Device Market, Australia, 2016 128
Figure 4 16: Total Orthopedic Robotic Assisted Surgery System Market, Australia, 2013 – 2023 131
Figure 4 17: Robotic Assisted Orthopedic Surgery Market, Australia, 2013 – 2023 (US$) 132
Figure 4 18: Robotic Assisted Orthopedic Surgery Market, Australia, 2013 – 2023 (AU$) 133
Figure 4 19: Drivers and Limiters, Robotic Assisted Orthopedic Surgery Market, Australia, 2016 137
Figure 4 20: Leading Competitors, Robotic Assisted Orthopedic Surgery Market, Australia, 2016 139
Figure 6 1: Press Release Summary 143
Figure 6 2: Press Release Summary 421

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology